Pharmaceutical & Specialty Chemicals

Broad-spectrum benzimidazole anthelmintic API for tablet and suspension formulations targeting systemic parasitic infections. Sourced in IP-grade micronised powder from WHO-GMP certified facilities.

Mucoactive expectorant API for oral liquid, tablet, and inhalation formulations in respiratory tract management. Supplied in IP/EP grade with assured dissolution and particle size specifications.

Core penicillin-class antibiotic API supplied as compactable trihydrate powder for capsule and suspension manufacture. Available in standard and compacted direct-compression grades.

Compacted ampicillin trihydrate optimised for direct compression tablet manufacture meeting IP pharmacopoeial standards. Preferred for high-volume oral antibiotic production lines.

Lipid-soluble artemisinin derivative used in antimalarial fixed-dose combination tablets and oral capsules. Strictly controlled IP-grade API with COA documentation for regulated export markets.

HMG-CoA reductase inhibitor API for cholesterol management tablet formulations. Supplied in IP-grade crystalline form with strict impurity profile and polymorph consistency.

HMG-CoA reductase inhibitor meeting USP monograph specifications for FDA-regulated markets. Ideal for high-potency tablet manufacture with controlled particle size distribution.

Macrolide antibiotic free base form used as an intermediate in azithromycin salt and formulation manufacture. Traded for downstream conversion and custom pharmaceutical synthesis.

Semisynthetic macrolide antibiotic in dihydrate form for tablet, capsule, and paediatric suspension formulations. Compliant with IP standards with verified microbiological purity.

Xanthine stimulant and analgesic adjuvant in anhydrous crystalline form to BP pharmacopoeial specifications. Used in analgesic combinations, energy supplements, and neonatal apnoea treatment.

Anhydrous caffeine meeting Indian Pharmacopoeia specifications for domestic and export pharmaceutical formulations. Supplied in food, pharmaceutical, and research grades.

Compacted cefixime trihydrate optimised for direct compression tabletting processes. Dual pharmacopoeial compliance (IP/USP) supports both domestic and US-regulated market supply.

Third-generation oral cephalosporin API in micronised particle size for enhanced bioavailability in oral suspensions and tablets. Micronisation ensures consistent dissolution performance in finished dosage forms.

Trihydrate form of cefixime for tablet and oral suspension manufacture, compliant with IP specifications. Widely used in paediatric and adult antibiotic formulations for regulated and emerging markets.

Broad-spectrum injectable cephalosporin sodium salt API, sterile-grade, for IV/IM preparation manufacture. Supplied with endotoxin testing and sterility documentation for injectable manufacturing.

Sterile-grade third-generation cephalosporin API for lyophilised injectable vial production. Supplied with validated sterility and endotoxin clearance data for hospital and critical care formulations.

Orally active prodrug ester of cefpodoxime used in tablet and dry powder suspension formulations. Traded in pharma-grade with confirmed polymorphic form and particle size distribution.

Broad-spectrum parenteral cephalosporin API for injectable formulation manufacture. Core product for hospital and export-market antibiotic supply chains across regulated territories.

Sterile sodium salt form of ceftriaxone for lyophilised injectable vial manufacture. Full sterility and endotoxin testing documentation provided for regulated injectable manufacturing.

Ceftriaxone sodium compliant with USP monograph specifications for FDA-regulated injection formulations. Preferred for North American and export injectable product lines.

Broad-spectrum antibiotic API in crystalline form for ophthalmic, otic, and oral formulations. Traded with documented bioburden and residual solvent profiles per IP pharmacopoeia.

L/N-type dual calcium channel blocker API used in antihypertensive tablet formulations. Traded in fine crystalline grade for precision dose tablet manufacturing.

Fluoroquinolone antibiotic hydrochloride salt API for oral tablet and IV infusion formulations. IP-grade with controlled impurity profile for domestic and export pharmaceutical manufacture.